ArcticZymes and TATAA Biocenter inks mutual distribution agreement for Europe

Published: 12.07.2011

ArcticZymes AS, Tromsø, Norway and TATAA Biocenter AB, Göteborg, Sweden today announce a mutual sales and distribution agreement for Europe.

The agreement will allow TATAA Biocenter to sell ArcticZymes heat-labile enzymes for use in contamination control (carry-over prevention, genomic DNA) through their sales channels and integrate ArcticZymes products in their broad range of courses. The heat-labile enzymes from ArcticZymes offers new exciting opportunities for integration of DNA contamination control in lab workflows and the strong network at TATAA Biocenter will be ideal to communicate the message to the research community.

Download full press release as pdf.